A targeted approach to reducing overutilization: use of percutaneous coronary intervention in stable coronary artery

Lisa M Behnke1, Amanda Solis, Stephanie A Shulman

  • 1OptumHealth Care Solutions, Fort Myers, FL 33967, USA. lisa.behnke@optum.com

Insights

Overutilization of percutaneous coronary intervention (PCI) in stable angina offers no survival benefit over optimal medical therapy (OMT). Shared decision-making can promote conservative care, improving patient value and reducing unnecessary procedures.

Area of Science:

  • Cardiology
  • Health Economics
  • Medical Ethics

Background:

  • Overutilization of medical care increases costs without adding value.
  • Percutaneous coronary intervention (PCI) is often overused in chronic stable angina, despite guidelines recommending optimal medical therapy (OMT) first.
  • Advances in PCI have increased its use, but recent evidence questions its benefit in stable coronary artery disease.

Purpose of the Study:

  • To examine the overutilization of PCI in chronic stable angina.
  • To highlight the importance of shared decision-making in managing stable coronary artery disease.
  • To advocate for evidence-based approaches over aggressive interventions in low-risk situations.

Main Methods:

  • Review of current practice guidelines and recent clinical evidence regarding PCI versus OMT for stable angina.
  • Analysis of patient understanding and decision-making processes related to PCI.
  • Exploration of shared decision-making models to promote conservative care.

Main Results:

  • PCI in stable coronary artery disease shows no reduction in overall mortality or major cardiac events compared to OMT.
  • Patients may be misinformed about the benefits of PCI over OMT.
  • Shared decision-making, considering health literacy and clinical evidence, can lead to more conservative treatment choices.

Conclusions:

  • Overutilization of PCI in non-acute settings provides no additional mortality benefit over OMT.
  • Promoting shared decision-making and patient understanding of evidence is crucial for appropriate PCI use.
  • Physicians should prioritize evidence-based discussions and shared decision-making before PCI in stable angina.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...